Please use this identifier to cite or link to this item:
https://doi.org/10.1093/cid/ciaa1280
Title: | Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity. | Authors: | Young, Barnaby E Ong, Sean WX Ng, Lisa FP Anderson, Danielle E Chia, Wan Ni Chia, Po Ying Ang, Li Wei Mak, Tze-Minn Kalimuddin, Shirin Chai, Louis Yi Ann Pada, Surinder Tan, Seow Yen Sun, Louisa Parthasarathy, Purnima Fong, Siew-Wai Chan, Yi-Hao Tan, Chee Wah Lee, Bernett Rötzschke Olaf Ding, Ying Tambyah, Paul Low, Jenny GH Cui, Lin Barkham, Timothy Lin, Raymond Tzer Pin Leo, Yee-Sin Renia, Laurent Wang, Lin-Fa Lye, David Chien Singapore 2019 Novel Coronavirus Outbreak Research Team |
Keywords: | COVID-19 cytokines immunology serology viral culture Antibodies, Viral COVID-19 Female Humans Immunoglobulin M Male Middle Aged Pneumonia, Viral Prospective Studies SARS-CoV-2 Seroconversion |
Issue Date: | 2-Nov-2021 | Publisher: | Oxford University Press (OUP) | Citation: | Young, Barnaby E, Ong, Sean WX, Ng, Lisa FP, Anderson, Danielle E, Chia, Wan Ni, Chia, Po Ying, Ang, Li Wei, Mak, Tze-Minn, Kalimuddin, Shirin, Chai, Louis Yi Ann, Pada, Surinder, Tan, Seow Yen, Sun, Louisa, Parthasarathy, Purnima, Fong, Siew-Wai, Chan, Yi-Hao, Tan, Chee Wah, Lee, Bernett, Rötzschke Olaf, Ding, Ying, Tambyah, Paul, Low, Jenny GH, Cui, Lin, Barkham, Timothy, Lin, Raymond Tzer Pin, Leo, Yee-Sin, Renia, Laurent, Wang, Lin-Fa, Lye, David Chien, Singapore 2019 Novel Coronavirus Outbreak Research Team (2021-11-02). Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity.. Clinical Infectious Diseases 73 (9) : e2932-e2942. ScholarBank@NUS Repository. https://doi.org/10.1093/cid/ciaa1280 | Abstract: | BACKGROUND: Key knowledge gaps remain in the understanding of viral dynamics and immune response of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. METHODS: We evaluated these characteristics and established their association with clinical severity in a prospective observational cohort study of 100 patients with PCR-confirmed SARS-CoV-2 infection (mean age, 46 years; 56% male; 38% with comorbidities). Respiratory samples (n = 74) were collected for viral culture, serum samples for measurement of IgM/IgG levels (n = 30), and plasma samples for levels of inflammatory cytokines and chemokines (n = 81). Disease severity was correlated with results from viral culture, serologic testing, and immune markers. RESULTS: Fifty-seven (57%) patients developed viral pneumonia, of whom 20 (20%) required supplemental oxygen, including 12 (12%) with invasive mechanical ventilation. Viral culture from respiratory samples was positive for 19 of 74 patients (26%). No virus was isolated when the PCR cycle threshold (Ct) value was >30 or >14 days after symptom onset. Seroconversion occurred at a median (IQR) of 12.5 (9-18) days for IgM and 15.0 (12-20) days for IgG; 54/62 patients (87.1%) sampled at day 14 or later seroconverted. Severe infections were associated with earlier seroconversion and higher peak IgM and IgG levels. Levels of IP-10, HGF, IL-6, MCP-1, MIP-1α, IL-12p70, IL-18, VEGF-A, PDGF-BB, and IL-1RA significantly correlated with disease severity. CONCLUSIONS: We found virus viability was associated with lower PCR Ct value in early illness. A stronger antibody response was associated with disease severity. The overactive proinflammatory immune signatures offer targets for host-directed immunotherapy, which should be evaluated in randomized controlled trials. | Source Title: | Clinical Infectious Diseases | URI: | https://scholarbank.nus.edu.sg/handle/10635/208937 | ISSN: | 10584838 15376591 |
DOI: | 10.1093/cid/ciaa1280 |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
Viral dynamics and immune correlates of COVID-19 disease severity.pdf | 1.88 MB | Adobe PDF | OPEN | Post-print | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.